News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cerbomed Reports Positive Intermediate Results from Epilepsy Pilot Study


6/8/2010 9:22:36 AM

ERLANGEN, Germany--(BUSINESS WIRE)--An evaluation has revealed positive intermediate results for the first three months of data from the clinical trials for the treatment of therapy resistant epilepsies with the world’s first device using transcutaneous vagus nerve stimulation (t-VNS®), from cerbomed gmbh. t-VNS® proves its good safety profile and scores high on user-friendliness, and there are also preliminary indications of its effectiveness, for the patients in the cMPsE01 pilot study.

Read at BioSpace.com


comments powered by Disqus
Cerbomed
 
 
Epilepsy

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES